These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9619136)

  • 1. Can antibiotics prevent heart disease?
    Harv Heart Lett; 1998 Jun; 8(10):6-7. PubMed ID: 9619136
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
    Fong IW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae and atherosclerosis.
    Ouchi K
    Jpn J Infect Dis; 1999 Dec; 52(6):223-7. PubMed ID: 10738358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chlamydia pneumoniae and arteriosclerosis: an innocent onlooker?].
    Vidal Verdú E
    An Med Interna; 1999 Jul; 16(7):329-32. PubMed ID: 10481330
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.
    Muhlestein JB; Anderson JL; Hammond EH; Zhao L; Trehan S; Schwobe EP; Carlquist JF
    Circulation; 1998 Feb; 97(7):633-6. PubMed ID: 9495296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of chlamydia and atherosclerosis.
    Muhlestein JB
    Am Heart J; 1999 Nov; 138(5 Pt 2):S514-5. PubMed ID: 10539862
    [No Abstract]   [Full Text] [Related]  

  • 7. New and emerging infectious diseases.
    Mandell GL; Townsend GC
    Trans Am Clin Climatol Assoc; 1998; 109():205-16; discussion 216-7. PubMed ID: 9601139
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment.
    Ewald PW; Cochran GM
    J Infect Dis; 2000 Jun; 181 Suppl 3():S394-401. PubMed ID: 10839723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arteriosclerosis caused by infection? A possible link between Chlamydia pneumoniae and atherosclerosis].
    Persson K; Boman J
    Lakartidningen; 1998 May; 95(20):2334-6, 2339-40. PubMed ID: 9630800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description and status of the azithromycin and coronary events study (ACES).
    Jackson LA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S579-81. PubMed ID: 10839763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of Chlamydia pneumoniae in atherogenesis].
    Barsukov AE; Svetlikov AV
    Vestn Khir Im I I Grek; 2000; 159(3):104-8. PubMed ID: 10983358
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atherosclerosis and Chlamydia pneumoniae].
    Larsen MM; Mørn B; Andersen PL; Østergaard LJ
    Ugeskr Laeger; 2002 Dec; 164(50):5920-4. PubMed ID: 12553110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics and heart disease. The story heats up.
    Harv Heart Lett; 1999 Jul; 9(11):4-6. PubMed ID: 10368527
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.
    Muhlestein JB
    J Infect Dis; 2000 Jun; 181 Suppl 3():S505-7. PubMed ID: 10839748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.
    Dunne MW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S572-8. PubMed ID: 10839762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis.
    Grayston JT
    Am Heart J; 1999 Nov; 138(5 Pt 2):S556-7. PubMed ID: 10539875
    [No Abstract]   [Full Text] [Related]  

  • 17. [Infection hypothesis for the pathogenesis of atherosclerosis--caused by Chlamydia pneumoniae?].
    Durkalec J; Hasik J
    Przegl Lek; 1999; 56(4):299-301. PubMed ID: 10494168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma.
    Cook PJ
    J Antimicrob Chemother; 1999 Aug; 44(2):145-8. PubMed ID: 10473220
    [No Abstract]   [Full Text] [Related]  

  • 19. Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease.
    Gupta S
    Am Heart J; 1999 Nov; 138(5 Pt 2):S539-41. PubMed ID: 10539869
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.